02.12.2021 • NewsAzelis

Azelis Acquires Austria’s Neupert Specialities

Azelis has acquired Neupert Specialities, an Austrian distributor specializing in food and health raw materials and ingredients in its local market, as well as in Germany and Switzerland. The deal strengthens the Belgium-based distributor’s presence in the growing Austrian food and health segment and in the region’s broader life sciences market, also adding cross-selling opportunities.

Financial details of the transaction were not disclosed.

“There is an outstanding compatibility between our two companies and we are very excited about the enhanced opportunity to expand the business under Azelis’ ownership by leveraging combined global principal relationships. Azelis’ strong track record in sustainability, especially their EcoVadis Platinum rating, as well as the technological capabilities, are of particularly great value to our joint food and health customer base,” said Peter Suppan, Neupert’s founder and managing director.

Headquartered in Vienna, Neupert specializes in products such as proteins, hydrocolloids, agar and sugar substitutes. The company was founded by Suppan and Norbert Resch, both of whom will continue to lead the business.

In late October, Azelis also agreed to acquire 90% of the shares in South Africa’s Umongo, a leading distributor of lubricants and metal working fluids. The transaction is expected to close by the end of this year. Umongo has its head office in Durban and employs 35 people. It also has an application laboratory. CEO Boston Moonsamy will remain with the company and continue to lead the business.

Author: Elaine Burridge, Freelance Journalist

(c) Azelis
(c) Azelis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.